MAPT and Alzheimer disease: Next, CSF from 29 normal controls, 5 FTLD-MAPT and 78 autopsy-confirmed cases of AD, primary tauopathies and FTLD-TDP were analyzed for MTBR-tau275 and MTBR-tau282 (Table 2).